In this study, CTT activated splenic B cells, which inhibited tumor metastasis, promoted the maturation of MDSCs through CD36-dependent MHC-II transfer and subsequently stimulated the Th1-dominant T-cell immune response. This evidence concerns the gene CD36 and neoplasm.